Basic info
Industry
biotechnology research
Sectors
CNS
Ediscovery
Structure-efficacy relationships (SER)
Health Care
Medical
In vitro preclinical efficacy
In vivo preclinical efficacy
Neurotoxicity
Date founded
2013
Funding rounds raised
Total raised
$1.5M
from 3 investors over 3 rounds
A
Afraxis, Inc raised $1.2M on May 13, 2010
Investors: Torrey Pines Investment
A
Afraxis, Inc raised $1.5M on September 19, 2008
Investors: Avalon Venture and Ambit Biosciences